Home page
Dear Ladies and Gentlemen,
On the behalf of Bulgarian Medical Society of Hematology (BMSH), it is our pleasure to present to your kind attention information for participation in EHA-BMSH BALKAN HEMATOLOGY TUTORIAL ON ''MYELOPROLIFERATIVE NEOPLASMS'' – November 14-15, 2024, which will be held at Ensana Aquahouse Hotel, Sts. Constantine and Helena, Varna, Bulgaria.
1. Organizer:
European Hematology Association |
BULGARIAN MEDICAL SOCIETY OF HEMATOLOGY (BMSH) |
2. Important dates:
Early bird registration of delegates | until 02nd of September 2024 |
Intermediate registration of delegates | from 03rd of September until 25th of October 2024 |
Late registration of delegates | from 26th of October 2024 and on spot |
Official Opening of EHA-BMSH BALKAN HEMATOLOGY TUTORIAL | 14th of November 2024 |
Closing of EHA-BMSH BALKAN HEMATOLOGY TUTORIAL | 15th of November 2024 |
3. Official Languages:
- English for EHA-BMSH Balkan Hematology Tutorial on "Myeloproliferative neoplasms"
During the event there will be no simultaneous translation.
4. Main Topics of EHA-BMSH Balkan Hematology Tutorial on "Myeloproliferative neoplasms":
- Myelodysplastic syndromes (MDS);
- Myeloproliferative neoplasms (MPN);
- Chronic Myelomonocytic Leukemia (CMML);
- Primary myelofibrosis (PM);
- Polycythemia vera (PV);
- Essential thrombocythemia (ET);
- Thrombosis in myeloproliferative neoplasms.
5. EBAH CME Accreditation:
EHA Hematology Tutorials are accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with up-to-date views on clinical policy will enable you to raise your professional level, resulting in the best treatment for your patients.
For additional information:
WASTEELS-Bulgaria – Official Agent
Contact person: Boryana Lazarova – mobile: +359 885 303 075, or е-mail: events@wasteels.bg
Program
November 14, 2024 - Thursday
12:00 – 19:00 Registration and accommodation participants
13:00 – 13:15 Opening Ceremony
I. Micheva (Bulgaria) & K. Döhner (Germany)
13:15 - 15:00 Session 1: Primary myelofibrosis
Lecture
K. Döhner (Germany)
Clinical Case 1: From remedy to risk: Unveiling secondary myeloma in primary myelofibrosis patients on ruxolitinib
S. Dimitrova (Bulgaria)
Clinical Case 2: Ruxolitinib induced planocellular skin cancer in patient with primary myelofibrosis
M. Popovska-Labacevska (North Macedonia)
Clinical Case 3: Advances in myelofibrosis treatment: a clinical case approach
- M. Crisan (Romania)
Panel discussion
All speakers
15:00 - 15:15 Coffee break
15:15 – 17:00 Session 2: Myelodysplastic syndrome (MDS) /
Myeloproliferative neoplasms (MPN) with an accent on CMML
Lecture
J. O’Sullivan (United Kingdom)
Clinical Case 1: CMML
V Musteață (Moldova)
Clinical Case 2: CMML
A Bogdanovic (Serbia)
Self-assessment case
J. O’Sullivan (United Kingdom)
Panel discussion
All speakers
17:00 – 17:30 Сателитен симпозиум фирма Bristol Myers Squibb
Тема: Как да подобрим лечението на пациенти с нисък риск МДС и
Миелофиброза
Модератори: проф. д-р Жанет Грудева-Попова, проф. д-р Илина Мичева
17:00 – 17:15 Как лекувамe нисък риск МДС: данните от проучванията с Luspatercept
проф. д-р Илина Мичева, УМБАЛ „Св. Марина“, гр. Варна
17:15 – 17:30 Ерата на новия JAK инхибитор – Fedratinib като стандарт за лечение на
пациенти с Миелофиброза
проф. д-р Жанет Грудева-Попова, УМБАЛ „Св. Георги“, гр. Пловдив
17:25 – 17:30 Дискусия
17:30 – 18:00 Сателитен симпозиум фирма Sobi
Тема: Предизвикателства в лечението на имунната тромбоцитопения
Модератор:проф. д-р Илина Мичева
17:30 – 17:45 Съвременни подходи за лечение на ИТП
доц. д-р Емил Спасов, УМБАЛ „Св. Георги“, гр. Пловдив
17:45 – 18:00 Клинични случаи от България
д-р Шениз Юзеир, УМБАЛ „Св. Марина“, гр. Варна
18:00 – 18:20 Фирмена презентация фирма Roche
Polivy: по-добра възможност в терапията на нелекуваните пациенти с
DLBCL
проф. д-р Жанет Грудева-Попова, УМБАЛ „Св. Георги“, гр. Пловдив
Нашият опит с Polivy в 1L DLBCL
д-р Александър Йорданов, УМБАЛ „Св. Иван Рилски“, гр. София
18:20 – 18:35 Фирмена презентация фирма Novartis
JAKAVI при Полицитемия вера
д-р Георги Иванов, УМБАЛ „Св. Иван Рилски“, гр. София
18:35 – 18:50 Фирмена презентация фирма Amgen
Ефикасност на комбинацията Kyprolis anti-CD38 mAb при първи рецидив на
ММ
проф. д-р Веселина Горанова-Маринова, УМБАЛ „Св. Георги“, гр. Пловдив
18:50 – 19:00 Фирмена презентация фирма Angelini Pharma
Дълбок, устойчив и клинично значим отговор дори и след редукция на
дозата на ICLUSIG (ponatinib), с минимизиране на проявата на нежеланите
лекарствени реакции
д-р Ради Луканов, УМБАЛ „Св. Марина“, гр. Варна
19:00 – 22:00 Вечеря
November 15, 2024 - Friday
09:00 - 10:45 Session 3: Myelodysplastic syndrome (MDS)
Lecture
S. Kordasti (United Kingdom)
Clinical Case 1: Myelodysplastic syndrome and autoimmune disorders: Friend or foe
I. Mandac-Smoljanović (Croatia)
Clinical Case 2: Low-grade myelodysplastic syndrome evolving into polycythemia vera JAK 2 positive
A. Tatic (Romania)
Self-assessment case
S. Kordasti (United Kingdom)
Panel discussion
All speakers
10:45 – 11:00 Coffee Break
11:00 - 13:00 Session 4: MPN, thrombosis & Essential thrombocythemia (ET)
Lecture
M. Sobas (Poland)
Clinical Case 1: A case of essential thrombocythemia complicated with portal vein thrombosis and live cirrhosis
N. Petkova (Bulgaria)
Clinical Case 2: Splanchnic vein thrombosis and myeloproliferative neoplasms
E. Grouzi (Greece)
Clinical Case 3: Thrombosis of unusual site in MPN
D. Lekovic (Serbia)
Self-assessment case
M. Sobas (Poland)
Panel discussion
All speakers
13:00 - 13:45 Lunch & Meet-the-experts
13:45 - 15:30 Session 5: Myelodysplastic syndrome (MDS) & myeloproliferative neoplasms (MPN)
Lecture
K. Grønbæk (Denmark)
Clinical Case 1: Double-mutant MPNs, Double or Bigger Trouble?
V. Graklanov (Bulgaria)
Clinical Case 2: Myelodysplastic syndrome
D Özmen (Türkiye)
Self-assessment case
K. Grønbæk (Denmark)
Panel discussion
All speakers
15:30 - 15:45 Coffee break
15:45 - 17:30 Session 6: Polycythemia vera (PV)
Lecture
G. Baerlocher (Switzerland)
Clinical Case 1: Post-PV myelofibrosis complicated by mesenteric venous thrombosis, gallbladder empyema and liver abscess
G. Tsvetkova (Bulgaria)
Clinical case 2: Polycythemia vera patient with expanded plasma volume
M. Lucijanić (Croatia)
Self-assessment case
G. Baerlocher (Switzerland)
Panel discussion
All speakers
17:30 – 17:45 Closing
I. Micheva (Bulgaria) & K. Döhner (Germany)
20:30 – 23:00 Dinner